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Bronr, New York
Impaired endothelial-dependent vasodilation has been demon-
strated in two animal models of congestive heart failure and in
the coronary circulation of patients with idiopathic dilated cardio-
myopathy . To determine whether this impairment contributes to
the abnormal peripheral vasomotor tone in patients with conges-
tive heart failure, the local vascular response to intraarterial
infusions of graded concentrations (10
-a
M to 10-s
MI
of acet)l-
choline (an endothelial-dependent vasodilator) and nitroglycerin
(a direct-acting vasodflator) was studied in the superficial femoral
artery of 19 patients with congestive heart failure (New York
Heart Association classes I to IV) and 6 age-matched normal
control subjects,
The local vascular response was determined from the arterial
blood flow relucity pattern obtained by trantealancous Doppler
ultrasonography. Acetylcholine, 10. 1 M, induced a pattern char .
acteristic of vasodilation in all
bix normal subjects ; mean blood
The skeletal muscle vasculalure dues not adequately dilate
in response to exercise in patriots with severe congestive
heart failure (I)
.
The absence of an adequate vasodilator
response during exercise may be partially responsible for
depressed peak aerobic capacity of these patients (21
. Ab-
normal peripheral vasomotor tone at rest and dot ing exercise
bas been attributed to increased sodium and Water content in
the arterial wall, neurohumorol activation and intrinsic ab-
normalities of the vascular smooth muscle (3).
Abnormalities of the vascular endothelium may also
contribute to increased vasomotor lone in congestive heart
failure . The vascular endothelium was recently shown to
release vasoactive substances that play an important role in
the normal regulation of vasomotor tone (4-6) . Endothelium-
derived relaxing factor modulates the vascular smooth mus-
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flow velocity for the group significantly increased from 11 .9 0, 2.7
to 44.8 ± 20
.9 cmls fp < 0 .05! . In contrast, the same dose of
acetylcholine induced a blood flow velocity pattern characteristic
of vasodilation in only 4 of the 19 patients with congestive heart
failure . Group mean blood flow velocity did not change signifi-
cantly. Nitroglycerin, 10-1 M, induced vasodilation in all 6
normal subjects but in only I of 19 patients. Nitroglycerin,
10_
5
M, was administered to 10 patients ; all 10 demonstrated a
pattern characterlitic of vasodilation .
Thus, a etylehnllne-medlnted endothelial-dependent vasodila-
time appears to be impaired In the peripheral vasculature of
patients with congestive heart failure
. Roth endothelial dysfuna
lion and abnormal vascular sn!voth muscle respoteiveness may
contribute in abnormal peripheral vasomotor tone.
fJ Am Call Cordial 1991;19:918-251
cle response to vasoactive hormones in both conduit
and resistance vessels (7) . It is chemically indistinguish-
able from nitric oxide and . like organic nitrate preparations
used clinically, mediates vasurelaxation through activation
of soluble guanylate cyclase in vascular smooth muscles
(8).
Release of endothelium-derived relaxing factor that is
induced by increased shear stress at the arterial wall
may be an important mediator of vasodilation during
physiologic states of increased peripheral blood flow (9),
such as (hose observed during maximal exercise
. Impaired
endothelial-dependent vasodilation has been reported in
conduit vessels in two animal models of experimental heart
failure (10,11) and in the coronary circulation of patients
with idiopathic dilated cardiomyopathy (12,13)
. Whether this
impaired vasodilation also contributes to abnormal vasomo-
tor tone in the lower limb skeletal muscle vasculature of
patients with congestive heart failure has not yet been
described.
Accordingly
. in this study we compared the local vascular
responses to intraarterial infusions of an endothelial-
dependent vasodilator. acetylcholine, and a direct-acting
vasodilator, nitroglycerin . i n the superficial femoral artery of
normal subjects and patients with congestive heart failure .
077 .5 .1097092155.46
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Table 1 . Clinical C'haraclerisnc+of 19 Patient,
CAD = coronary ahery dvnntm, DM = diabetes mellitus; EF = ejection friction (051=910 by ladionuelide
'o ab_ph; in all 10 subjects4: F = fsmak; HTN = hypertension; WC = miopathic dilated ca&-yopahy :
M =.l,NY HA Class = New Awl Heal+ As a6ro r-oi . .I,t s, N = Deism .
Methods
Study patients . (Table 1) . Nineteen amr datory patients
with chronic congestive heart failure of at 'cant 3 months'
duration were studied . Their clinical ch4acteristics are
summarized in Table 1 . In seven palierI ventricular
dysfunction was primarily due to coronary artery discos :-as
determined by coronary angiography or 27revious docu-
mented myocardial infarction . Three of
_:lc
seven were
insulin-dependent diabetic patients and tw' had a remote
history of hypertension. The etiology of ;e[I curricular
dysCurctiun was idiopathic dilated carsn nyopathy in 12
patients . Three of these 12 also were i- ;;ulindependent
diabetic patients . and I had a history of lot - le bypertension
that was not considered the primary cause of left ventricular
dysfunction . No patient was hypenensivc at the time of the
study .
Ail patients were receiving medical therapy for conges-
tive heart failure. The regimen included diuretic drugs irk all
patients, digoxin and angiotensin-converting enzyme inhibi-
tors (either captopril In = 141 or enalapril In - 4!) in 19
patients, long-acting nitrate preparations in 6 patients and
investigational phosphadiesterase-inhibiting agents in II pa-
tients. Heart failure was well compensated in all patients .
None had peripheral edema,
Four men and
111'0 510500 served ae' naritmf caerrnl
subjects. In view of the age dependence of endothelium-
induced vasodilation 1141, normal subjects were matched for
age with the patients with congestive heart failure (mean age
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50 = I I in the normal group vs . 55 ± 12 years in the patients
!p = NS!).
The normal subjects had no cardiac disease or
chronic medical condition. The sit 0y protocol was approved
by the Committee on Clinical investigations of the Albert
Einstein College of Medicine and written, informed consent
was obtained from all patients an! normal subjects.
Study proincol . Patients were studied in a fasting state, in
a quiet temperature- and humidity-controlled room . All
cardiovascular medications were withheld for -24 h before
the study . After administration of 1% lidocaine for local
anesthesia- a 3F- 10-cm polyethylene catheer was inserted
into the common femoral nursery for pressure monitoring and
local intmnrterial drug infusions. Proper positioning of the
catheter tip was verified by two-dimensional c!t-lsoludl and
an adequate pressure waveform . The subjects were then
allowed to rest for ?30 min .
All drugs were mixed in 490 dextrose in water on the
day of the study. Ail concentrations are reported as final
regional blood concentrations . assuming that an average
common femoral blood flow was 400 mllmin
(15)
. Drugs
were infused at a rate of I
ml/min
for 2 min through the
common femoral artery cathcler by volumetric pump or by
hand-held injection in the following sequence : mannitol,
10- M (vehicle control) ; acetylcholine, 10_
1
M, 10-7 M,
l0 - " M and 10- ` M: nitroglycerin . 10
-
M (20 nglml) and
10 -71 M 12,000
111
Acetylcholine. an endothelial-dependent vasodilating
agent . was obtained from a commercially available pre-
I'1 N.,
Age(yr)I
Gcnd,
EF
!%I
NYHA
C.-
D'rN
Did,, Hid., DA
Swum
Chokslerd
Im,1dll
I 63151 15 Ill FAD 2491
66'1 29 III CAD 216
7061 II CAD lit
MUM 1, Iv CAD no
19, E I CAI
6VF
CAI i 167
49/0
79
CAD
PI
091E
=6 II3C 346
57161 III tDC 71.3
III Nlihl Is' 1111 148
II
17TF
Il
IDC
320
12 47:1.1 III
inc
174
13 59 61 14 11 IDC 178
14 13491 10 ill 117C 2114
15 40F 2o n IX 179
16
?5154 Is DI IDC 131
11
6211' II Ill IDC 214
Ia 71551 11 IDC 170
19 61957
y
In IDC
123
Mean 5x
SD I'_ 6
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paration IMiochol) containing acetylcholine . 2 mg/ml . in
mannitol solution . Nitroglycerin (Tridil), a direct-acting
endothelial-independent vasodilator, was obtained its a
5-mg/m1 solution in 30% ethanol and 30% propylene glycol .
Nitroglycerin was administered intraarterially at a dose of
10-7 XI (20 ng/ml) to all 19 patients, which results in serum
concentrations achieved during intravenous infusion of ni-
troglycerin at 50 to too sag/min (16). Because the response to
nitroglycerin, t0 - M . was minimal in the first 9 patients . the
drug was also administered at a dose of 10_
s
M in the last 10
patients .
before and al completion of each 2-min infusion, mean
arterial pressure and heart rate were recorded on photo-
graphic paper (Electronics for Medicine Model VR6). After
each infusion . all catheters were cleared of active drug and
flushed with heparinized solution. Subsequent infusions
were administered at 5-min intervals when all variables had
returned to prier baseline values . Superficial femoral artery
blood flow velocity was determined before and throughout
each drug infusion with use of the ulrasourd techniques
described here .
Doppler ultrasonography. Ultrasound examination was
performed with use of a 7 .5-MHz duplex mechanical trans-
ducer connected to a Hewlett-Packard Somas 100 Ultra-
sound System . With the patient supine . the transducer was
positioned an the medial portion of the patient's thigh at the
inferior border of the femoral triangle . the superficial fen--
oral artery was identified and carefully scanned to determine
its origin and course and the presence and extent of athe,-
oma, when relevant . Exclusion criteria included extensiTe
arterial wall atheromatous changes, arterial narrowing or a
Doppler signal consistent with significant proximal anteri'd
slertosis, or both . The origin of the vessel was avoided
because of changes in velocity profile at the branching pain .
Ona the optimal portion of the artery was visualized, it :
position of the transducer was marked on the skin . Before
any Doppler measurements were attempted, great care we,
taken to visualize the vessel at its largest diameter w ;' rl
vessel walls parallel in the two-dimensional sector imag
When the waits of the vessel are pzrzllel, one can assure
that the Ultrasound beam is directed parallel to the longitu
.
dinal axis of the vessel (angle theta close to 0°) (15) .
Transducer position was then adjusted to minimize the
incident angle of the ultrasound beam . An angle of <60' was
obtained in all instances and was kept constant within any
subject. Automatic internal correction fur the Doppler angle
was utilized with the aid of an on-screen cursor .
Once optimal visualization of the vessel had been
achieved, a 2- x 3-mm sample volume was placed in the
center of the vessel and fine adjustments of its position were
made until a narrow Doppler spectrum with a whistling audio
signal was obtained . Under these conditions . the maximal
velocity . corresponding to the central position in a parabolic
velocity profile, was recorded
. Ihis variable tended to
overestimate the actual velocity across the whole cross
section of the vessel
(17)
;
however . the overestimation was
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systematic in all patients studied . This approach was chosen
to maximize reproducibility of flue Doppler signal
. Tile
coefficient of variance for baseline determination of mean
blood flow velocity was 6.3%% . Doppler .Audits were re-
corded on 0 .5-in . (I .27-cm) tape with a commercially avail-
able videocassette recorder for later analysis. Analysis of the
Doppler mean velocity was performed by integrating the
darkest portion of the spectral display throughout systole
and diastole and dividing by the RR interval . The results of
five consecutive cycles in the last 30 s of the infusion were
averAged . In ease of alThyihmias, extrasysreltc and post-
extrasystolic heals were excluded from analysis .
Transrrrtoveatts Doppler ftao velocity meaxnreroents in
the uoper-hria(femoral artery were compared with determi-
nations of blood flaw obtained by venous occlusion plethys-
mography in the lower limbs of €out normal subjects and five
patients with congestive heart failure with use of a mercury-
in-Silastic strain gauge . as previously described (181 .
Doppler blood flow velocity and limb blood flow by plethys-
mography were determined at 15-s intervals for 3 min
after 5 min of circulatory arrest induced by a pressure cuff
inflated above the knee to 240 mm Hg . In all subjects, the
two methods were highly and significantly correlated Ir >
0.89, p < 0 .011 . Similarly
. we have reported (19) an excellent
correlation between Doppler blood flow velocity in the
superficial femoral artery and limb blood flow measured by
plethysmography after intraarterial administration of amei-
none and digoxin and after simultaneous administration of
amrinonc and digoxin.
Data analysis. All values are presented as mean values *-
SO . Mean blood flow velocity . heart rate and mean arterial
pressure were analyzed for normal subjects and patients
with congestive heart failure with use of repeated measures
analysis of variance followed by Seheffd post-hoc testing for
statistical significance . Linear regression analysis was per-
formed for selected clinical variables, Statistical significance
was accepted at the 95% confidence level Ip a 0.05).
Results
Response to Acetylcholine (Fig. I and 2)
Normal subjects (TAbte 2) . A representative example of
the change in Doppler-derived blood flow velocity profile in
the superficial femoral artery induced by intraarterial admin-
istration of acetylcholine, t0
-
s Al, in a normal subject is
depicted in Figure I . At baseline the blood Bow velocity
profile at rest is characterized by as initial systolic forward
flow velocity {positive) followed by an early diastolic flow
reversal (negative velocity) and later to diastole by a second
phase of forward flow. After administration of acetylcholine,
changes in the blood flow velocity pattern characteristic of
vasodilation are observed (201
. Peak systolic and mean blood
flow velocities increase, whereas early diastolic reversal of
blood flow completely disappears arid forward flow contin-
ues until the end of the cardiac cycle. Mean blood flow
JACC Vol. 19, No. 3
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Figure 1. Spectral display of blood flow velocity obtained by
transculancous Doppler ultrasonegraphy in the superficial Femoral
artery of n normal subject- A, Baseline Imcing . Idean blood flaw
velocity is 13 emus. B, After intrearlerint infusion of acetylcholine .
10-1 M, mean blood Row velocity is increased to 59 .9 emls.
velocity increases from a baseline value of 13 to 59
.9 curls
after acetylcholine infusion .
In normal subjects (Table 2) group mean blood flow
velocity increased significantly from 11 .9 t 2.7 to 44.8 t
20.9 cm/s (p < 0.05) after intraarterial administration of
acetylcholine, 10-5 M, which produced a blood flow velocity
pattern characteristic of vasedllation in every normal sub-
ject. Group mean blood flow velocity increased from 11
.7 1.
4 to 33.8 ± 21 .2 curls (p < 0 .05) after administration of
acetyleholine, l0'6 M, which produced n pattern character-
istic of vasodilation in all but one normal subject. Acetyl.
Figure 2 . Group mean blood now velocity at baseline and after
inemesing doses of ecetylcholine in d normal sahjects *l1d baN . 7
patients with i9cbemic cardiomyopathy (open banal and 12 patients
with idiopathic dilated cardiamyopathy (striped hues). Values are
mean values 2 SEM . "Significant increase in mean velocity com-
pared with baseline values (p < 0.05) . IAchl = acetylcholine
concentialien.
I
0
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Table 2 . Vnsculo- Restmnse to Acetytchntine
. 10
-` 41, in six
Normal sable, is
'p 2 0.03 vs- baseline. Ach - ac elykhuloe: H - bardira : HR -bun
rate MAP - c:co.^. _ _riot pressure : 54Bf 1 - .m _, Nc7 Row xel-ty .
choline . 10 - M and 10
-s
M, and mannitol vehicle control
did not alter mean blood flow velocity or mean blood flow
velocity patlcre .
Dilated eardlonyapathy (Tahk 3). In 12 patients with
idiopathic dilated catdiomyopathy, group mean blood flow
velocity did not change significantly (B .2 ± 4.1 cmfs before
vs . 13-9
.
19 .4 cmiv after) in response to intraanerial
Take 3 . Vascular Response i6 Acetyleholinc, 10- ' Y7 . in 19
Patients With Congestive Heart Failure
HR MAP - IIBFV
fmio 'I On . Hgl Icmlc)
Pt No
.
B
Ash
B
Ash
B 599
tschemtccardiomyopntyIn=7) _
:2.9
4.3
47
3.4
19"
36.5
6. t
12A
121
Iliiotathic l2hbled Cardiomycpalhs in = 12)
50 66 94 98 4.9 27.4
11e 73 69 71 7.7 11
118 119 76 74 10.8 9,2
88 95 105 105 129
57.6
112
116 88 91 9.6 12.6
02
87 911 104 17.2 16 .8
72 75 66 70
7.8 2 .4
15 90 98 94 98 8.3 8.5
16 96 99 05 97 7.5 0,1
17 65 e0 102 97 4.2 0,7
IS 60 68 89 94
8
.3
8,1
19 103 101 97 100 2.8 4 .3
Mean a5
90 68 92 8.2 13 .9
Si) 21 10
12 13 4.1 15 .4
"Preserved oasodilalor response In acetylcholine . All abbreviations as in
Tables I and 2 .
sib'-
No .
Age lyre
Gender
112
11101 1
Map
fmmHM1
MHFV
Ibnbl
B Ach B uul B
Ach
1 571.5, 56 57
99
94 73
13.6
481M SO
51
91 93 14 .4 74.9
354M 61 66 96 96 13 59.9
42F 72 90 88 42.1
s9'P 88 81 100 ''59 1 ,1273.2 38 .9
6 555t 80 84 93 90
10.1 59 .3
\teas 90 67 711 94 93 11.9 4A M
S1) 11 13 17 5 4 27 20.9
I 104 105 91 81 13.1
67 71 411 51 3,5
3 77 60 193 103 4A
4 97 79 91 97 2 .5
5- 74 78
96
83
6
.9
8' 85 87 94 93 14 .9
7 87 37 97 10? 6 2
Mean
BI
41 8 Me 1 .3
SD 13 14 20 i8 48
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Table 4, vascular Response to Nitroglycerin
Haselir e' 10.7 x 2.4 7.4 t 4.7 5 .7 x 4.1
NTG' 21 .7 U 3.5t 10.9 ± 4.61 29 .7 s 12,
'All slues are mean blood flow velocity (cMs)r tp < 0.05 versus
baseline . CHF = cangentive heart failure : NTG = nitroglycerin .
administration of acetylcholine, l0 - ' M, which produced a
blond flow velocity pattern characteristic of vasodilation in
only two patients (Cases 8 and 11) . In the remaining 10
t.a.icats writ id :a(sathic dilated caidjomyopaihy, acetylcho-
line, IO -s M, did not alter mean blood flow velocity .
Acetylcholine . lo -6 M, 10
-7
M, 10
g
M, and mannitol
vehicle control did not affect mean blood flow velocity or
blond flow velocity pattern,
Ischric cardiomyopathy (Table 3). In seven patients
with ischemic cardiomyopathy, group mean blood flow
velocity did not change significantly, that is, 7 .3 ± 4.8 versus
12 .4 ± 12 .1 cm's after intraarterial administration of acetyl-
choline, 10 -5 M, which produced a blood flow velocity
pattern characteristic of vasodilation in only two patients
(Cases 5 and 6). In the remaining five patients, acetylcholine,
10 - ' M, did not change mean blood flow velocity . Acetyl-
choline, 10-" M, 10 - ' M and t0_a M, and mannitol vehicle
control did not alter mean blood flow velocity or blood flow
velocity pattern .
Heart rate and mean superficial femoral artery pressure
did not significantly change after intraarterial administration
of acetylcholine at concentrations ranging from 10_e M to
10 -s itt in normal subjects and patients with idiopathic
dilated or ischemic cardiomyopathies .
Response to Nitroglycerin (Table 4)
Normal subjects. Mean group blood flow velocity in-
creased from 10 .7 *_ 2.4 to 21 .7 ± 3 .6 calls (p < 0 .05) after
intraarterial administration of nitroglycerin, 10 - ' M, which
produced a blood flow velocity pattern characteristic of
vasodilation in every normal subject .
Patients with cardiomyopathy . In the 19 patients with
idiopathic dilated and ischemic cardiomyopathy, intraarte-
rial administration of nitroglycerin,
10-7
M, increased group
mean blood flow velocity slightly from 7.4 ± 4 .7 to 10.8 ±
4 .6 cm's (p < 0.05) and produced a blood flow velocity
pattern characteristic of vasodilation in only I patient . To
better assess the functional capacity of the cyclic guanosine
monophosphatc-dcpendent vasodilator mechanism in our
patients, nitroglycerin at a dose of 10-'M was administered
to the last 10 patients . Group mean blood flow velocity
increased from 5.7 ± 4,1 to 28.7 ± 12 em/s (p < 0 .05). All 10
patients demonstrated a blood How velocity pattern charac-
teristic of vasodilation .
Heart rate and mean superficial femoral artery pressure
did not change significantly after imraarterial administration
of nitroglycerin.
Discussion
The present data indicate that acetytcholine-mediated
vasodilation is substantially reduced in the peripheral circu-
lation of patients with congestive heart failure . This finding
suggests that impaired endothelial-dependent vasodilation
may contribute to the abnormal vasomotor tone present in
congestive heart failure .
Previous studies. Our data in the lower limb peripheral
vasculaturc are in agreement with preliminary reports in the
forearm circulation in patients with congestive heart failure
(21,22) and extend previous work by Treasure et al . (13) and
t'orstermann et al. (12) that demonstrated impaired acetyl-
choline-mediated vasodilation in the coronary circulation of
patients with idiopathic dilated cardiomyopathy. Similar to
Treasure et al .
(13), who reported an acetylcholine-induced
vasodilator response in only one of eight patients, we
observed acetylcholine-mediated vasodilation in only one of
our seven patients with primary idiopathic cardiomyopathy
with normal cholesterol and without diabetes mellitus or a
history of hypertension. Whereas Treasure et al
. (13) only
studied men with idiopathic dilated cardiotnyopathy
. our
patient group included five women as well as seven patients
with cardiomyopathy due to coronary artery disease. Three
of the five women studied demonstrated a characteristic
pattern of vasodilation in response to acdylcholine . Thus,
three of our four patients who had a preserved vasodilator
response to acetylcholine were women . The significance of
this observation is unclear. Gender-related differences in
endothelial .dependent relaxation have not been previously
suggested and were not readily apparent in our normal
control population .
Clinical predictors of response to acetylcholine . Left ven-
tricular ejection fraction was significantly greater ;,27.g% vs .
20.3%, p < 0
.05) and New York Heart Association func-
tional class was lower (2 vs . 2.9, p < 0 .05) in the 4 patients
with preserved vasodilator response to acetylcholine than in
the other 15 patients . However, neither left ventricular
ejection fraction nor functional class were significantly cor-
related with mean blood flew velocity response to intraarte-
rial administration of acetylcholine, 10 -' M. The clinical
significance of these observations is uncertain in view of the
small number of patients with a preserved response to
acetylcholine .
Possible mechanisms all impairod endothelial-dependent
vasodilation after nitroglycerin . The mechanisms that are
responsible for impaired acetytcholine-mediated vasodila-
tion in congestive heart failure are still poorly understood,
Nitroglycerin was administered to assess the functional
integrity of cyclic GMP-dependent vasorelaxalion in the
Normal
Subjects Patients With CIII'
fn=6) (t- 19)
NTG, NTG, NTG.
ID- 'M 10 - 'M 10 -, M
lr=6) fn=191 at 10)
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vascular smooth muscle. In agreement with previous reparls
11 .23 24), the peripheral vasodilator response to nitroglyc-
erin was reduced in patients with congestive heap failure
when compered with values in ewrnwl subjects . A uasudila-
tor response to nitroglycerin was elicited by increasing
the dose of nitroglycerin to It) M. Seven patients with
idiopathic dilated cardiomyopathy who did eel respire to
to-1 M of acetylcholine experienced n vusodilotor response
to 10 -s M of nitroglycerin. Thus . despite a reduced potency
of nitroglycerin, the intracellular mechanisms mediating
cyclic GMP-dependent vasodilmion can be activated in
patients with congestive heart Nonetheless . ourdata
suggest that an abnormal cyclic GMP-mediated vascular
smooth muscle relaxation in patients with Congestive heart
failure may be partially responsible for the impaired re-
sponse to acetylcholine 125 .261 .
A nonspecific aaetaaoiat of rasnrfilmnr aopaein • could
have contributed to the blunted response to acetylcholine
and nitroglycerin . However . patients with congestive heart
failure have been reported to have preserved vascular re-
sponses to nonspecific vasodilating stimuli, such us postkch-
emic reactive hyperemia 1271 and adenosine (13). Activation
of the sympathetic nervous system and other neurohumoral
systems may also contribute to abnormal vasomotor tone in
congestive heart failure. Heart rate and blood pressure worn
stable throughout our study
. suggesting that the local intraar-
terial infusions used were not associated with acute activa-
tion of
the sympathetic or other neurohumoral systems . The
effects of chronic ncurohumoral activation on endothelial-
dependent vasudilation in congestive heart Failure remain to
be determined in future investigations .
Possible mechanisms of impaired vascrdar response to
acelykhsline. The impaired vascular response to acetvlehm
line may be secondary to muscarinic rocepror dysFunclion or
to abnormal endothelial synthesis or release of endothelial
derived relaxing factor. or both . In vitro experiments using
thoracic aortic rings from mts with congestive heart failure
after surgically induced myaardiel infarction (11)
and iso-
lated vascular rings from epicarttial coronary arteries from
patients with idiopathic dilated cardiomyopathy 1121 have
demonstrated impaired acetylcholine-mediated vaso-
relaxation although the response to other nonmuscarinic
endothelial-dependent vasureluxing agents was preserved .
Thus, a specific defect in peripheral vascular muscarinic
receptor function could have contributed to the impaired
vascular response to acetylcholine in our patients . Reduced
density of myocardial muscarinie receptors has been previ-
ously reported in a canine model of chronic ventricular
pressure overload (28) but not in the failing human heart (291 .
Tine cause of redrrred endolhefitf-dependent vasudifatiatt
in congestive henry
failure is not apparent from our results .
Preliminary work suggests that both prostaglandin and
lymphokiaes are potential mediators of endothelial dysfunc-
don . Cyclooxygenase inhibition with indomethaein has par-
dally restored acetylcholine-mediated, endothelial-dependent
vasodilation in a canine model of congestive heart failure (10) .
KAI1.. i I AL .
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Tumor necrosis factor. which has been reported to he elevated
in the serum of patients with congestive heart failure (30). and
associated lymphakines . inierteukin 2 and interieukin a . have
been dcmumtrated to inbibil endothelial-dependent vasudila-
tion in vic-v 4311
.
further clinical investigations will help to
determine whether these mediators of inflammation are in-
volved in the reduced endothelial-dependent vasudilation in
patients with congestive heart failure .
Potential limitations. Although discontinued for a24 h
betorc study, the medications administered W our patients
may hase influenced our results. Whereas digitalis glyco-
sides have been demonstrated to inhibit both endothelial
release of endothelial-derived relaxing factor and its action
on vascular smooth muscle, acetylcholine did induce vasy-
dilalion in four patients treated with digoxin 132). Moreover.
Treasure et al . 1131 reported similar responses to intraeoro-
nary acetytchetine in patients with dilated cardiomyopathy
whether or not they were treated with digoxin . The impaired
response to acetylcholine and nitroglycerin is unlikely to
have been secondary to nitrate tolerance . Indeed . only six
patients were treated with long-acting nitrate preparations
and a nitrate-free interval of 24 h appears adequate to avoid
inlerance 1331 . Short-term administration of an angiotensin-
convening enzyme inhibitor has been reported 1341 to in-
crease endothelial-dependent vasodilation in patients with
essential hypertension. Nevertheless . 14 of If patients re-
ceiving maintenance therapy with an angiolensin-conver
.iag
enzyme inhibitor did not demonstrate vasodilation in re-
sponse to acetylcholine in the current study . Eleven patients
were receiving various investigational cardiotanic agents
that act primarily through specific phosphodiesterase inhibi-
tion . Although these agents mediate vasodilation primarily
through cyclic adenosine monophosphate (AMP)-dependent
protein phosphorylation. an effect on cyclic GMP-mediated
vasudilation cannot be excluded 1351 .
As frequently observed chuikaity . several disease, way
have contributed to the etiology of congestive heart failure in
our patients . Atherosclerosis. present in the coronary vas-
culniure of seven of our patients . has been demonstrated to
impair acetylcholine-mediated vasodilation in an animal
model (36) and in the coronary circulation in humans
(37,38)
.
Two of seven patients with documented coronary artery
disease deutonsteated a preserved peripheral vasodilator
response to acetylcholine
. Although none of one patients
were hypertensive at the time of the study . a history of labile
hypertension was elicited in three patients . Hypertension
has been demonstrated to impair endothelial-dependent
vasudilation both in animal models (39 .40) and in the human
forearm vasculature (41,42). One of the three patients with a
history of nypettension demonstrated a preserved vasodila-
tor response to acetylcholine . whereas the remaining two did
not. Diabetes mellitus has been reported to impair acetyl-
choline-mediated vasudilation in animal models (43,44) .
Two of six patients with insulin-dependent diabetes mellitus
had a preserved vasodilator response to acetylcholine
. Hy-
pcrcholesterolemia has also been demonstrated to attenuate
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endmhelial-dependent vasndilauan, even in the ahsei cc of
atherosclerosis 145,46] . Of the seven patients with 'crum
cholesterol levels m220 mg'dl, three had a preserved vaso-
dilator response to acety'Icholiue .
Thus, although atherosclerosis, hypertension, diabetes
mellitus and hypercholesterolemla may have contribu ed to
the vascular responses observed in this study . these diseases
cannot entirely account for our findings . Indeed, the vascu-
larrespoase to ace.ytcholine was impaired in six o€ the seven
patients with idiopathic dilated cardiomyepathy who had no
evidence of nthetweelerocis, hypertension, diabetes mellitus
or hypercholesterolemia. Abnormal endutheliat-dependent
vasodilation appears to be related solely to the presence of
congestive heart failure in these seven patients .
The uftrasorrnd leckniques used in the present .study did
not allow accurate detection of small changes in blood vessel
diameter. Thus, calculation of volumetric slow was not
attempted . Although the increases in mean blood
flow ve-
locity observed could have resulted from a decrease in
superficial femoral artery diameter, this appears unlikely for
several reasons .
1
. The blood flow velocity waveform after acetylcholine
infusion, observed in the current study, is chatacierstic of
peripheral vasodilation, as previously demonstrated in the
canine femoral artery (20) and the human superficial femoral
artery (47) with the use of invasive electromagnetic flow
meters, The loss or diastolic flow reversal can be attributed
to arteriolar vasodilation, with consequent decreased wave
reflections from the distal vaseulature (20,48) . Thus, our
findings demonstrate that acetylcholine mediates vasodila-
tion in peripheral resistance vessels
.
2, A 30%
to 50% reduction in superficial femoral artery
diameter would have been required to account for the two-
to threefold increases in moan blood
flow velocity observed .
If present, such large changes in blood vessel diameter
'would have been detected by sour ultrasound techniques .
3
. The mean blood flow velocity obtained by Doppler
ultrasound closely correlated with blood flow measurements
obtained by venous occlusion plethy
smog
raphy (19).
Conclusions. Acetylcholine-mediated vasodilation ap-
pears to be substantially reduced in the peripheral arterial
circulation ofpatients with congestive heart failure, whereas
a vasodilator response can still be elicited by a high dose of
nitroglycerin
. These findings suggest that vascular endothe-
lial function is impaired in patients with congestive heart
failure .
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